Targeted therapy for human epidermal growth factor receptor 2-positive breast Cancer: Can there be too many active drugs? Journal Article
| Authors: | Chandarlapaty, S.; Modi, S. |
| Article Title: | Targeted therapy for human epidermal growth factor receptor 2-positive breast Cancer: Can there be too many active drugs? |
| Keywords: | protein kinase b; advanced cancer; breast cancer; epidermal growth factor receptor 2; editorial; phosphatidylinositol 3 kinase; mammalian target of rapamycin; tanespimycin; tumor growth; trastuzumab; everolimus; lapatinib; neratinib; pertuzumab |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 23 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-08-10 |
| Start Page: | 3111 |
| End Page: | 3113 |
| Language: | English |
| DOI: | 10.1200/jco.2011.36.4091 |
| PROVIDER: | scopus |
| PUBMED: | 21730267 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 3 October 2011" - "CODEN: JCOND" - "Source: Scopus" |
